Ex-Aussie prime minister Kevin Rudd was physically restrained from belting the Chinese negotiator during fiery climate change negotiations in 2009, according to former British PM Gordon Brown.

Rudd denies the allegation, although his competitive streak is well documented.

All hail ‘The Handball King’:

TO MARKETS:

Overnight, Wall Street whipsawed all over the shop before finishing in positive territory.

Morningstar called it “a tug-of-war between stocks that thrived amid lockdowns and those that stand to benefit most from a reopening economy.”

Tech stocks in particular – which outperformed during COVID-19 – were viewed as expensive by investors, who “favoured shares that stand to gain most as ongoing vaccine deployment allows economic restrictions to be lifted”.

The local bourse has moved lower in morning trade, with the benchmark ASX 200 index currently down 32 points – or 0.48 per cent – to 6,806.7 points.
 

WINNERS

Here are the best performing ASX small cap stocks at 12pm Wednesday February 24:

Swipe or scroll to reveal the full table. Click headings to sort. Stocks highlighted in yellow made market moving announcements

 

Bill Beament, boss of $12.2 billion gold miner Northern Star (ASX:NST), will cornerstone a big $58m funding package to advance Venturex Resources’ (ASX:VXR) Sulphur Springs copper-zinc project towards production.

Beament, to be appointed Venturex exec director in July, will own a dominant 26 per cent of the advanced explorer/project developer on completion.

Explorer Carawine Resources (ASX:CWX) soared +100 per cent after recording multiple drilling intersections above 20g/t gold at ‘Hercules’, part of its Tropicana North project in WA.

“These exceptional first results from our maiden drilling program at Tropicana North are highly significant,” Carawine managing director David Boyd said.

“This gives us high confidence that Hercules could develop into a major new gold deposit.”

Queensland based energy retailer Locality Planning Energy (ASX:LPE) was rewarded for a solid half yearly result.

And AdAlta (ASX:1AD) soared to a one-and-a-half year high after its lead drug candidate — a molecule inspired by shark antibodies — received orphan drug designation in the US for the treatment of a rare lung disease.

 

LOSERS

Here are the worst performing ASX small cap stocks at 12pm Wednesday February 24:

Swipe or scroll to reveal the full table. Click headings to sort. Stocks highlighted in yellow made market moving announcements